Mark Finn
Mr. Finn serves as an independent director on the Legg Mason Partners Fund Board. He is a member of the advisory board for Auven Therapeutics, a private equity fund focused on life sciences. Mr. Finn is also a co-founder of New Ventures Select LLC, a fund focused on royalties, and New Ventures LLC and New Ventures III, both early stage venture capital funds. New Ventures LLC is a lead investor in Cibus.
Mr. Finn served as a Trustee of the Virginia Retirement System and Chairman of its Investment Advisory Committee and as Chairman of the Investment Operations Advisory Committee for the State of Alaska. He was also a member of the Chicago Mercantile Exchange’s Advisory Committee on Managed Futures.
Mr. Finn has taught investments at the University of Virginia Darden Graduate School of Business and lectures on investments at the Mason Graduate School of Business at the College of William and Mary, where he received an MBA.